Last reviewed · How we verify

NCT07142720

Rapid Effects on Antioxidant Status, Immune Alertness, and Regenerative Activity

Completed NA Last updated 30 January 2026
What this trial tests

NA trial testing A low dose of seaweed extract in Immune Surveillance in 20 participants. Completed in 31 July 2025.

Timeline
1 November 2022
Primary endpoint
31 January 2024
31 July 2025

Quick facts

Lead sponsorNatural Immune Systems Inc
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposebasic science
Enrollment20
Start date1 November 2022
Primary completion31 January 2024
Estimated completion31 July 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Natural Immune Systems Inc

Who can join

Adults 18 to 75, any sex, with Immune Surveillance or Stem Cell Surveillance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical study aims at documenting rapid effects after consuming single doses of test product, when compared to consuming a placebo. A double-blind, placebo-controlled, cross-over study design will be used.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Immune Surveillance

Currently open trials in the same condition.

Other Natural Immune Systems Inc trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07142720.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing